Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,122 total articles
Miles Christen Brooke, Vice President of Human Resources at RGC Resources Inc. (NASDAQ:RGCO), executed a share purchase on July 1, 2026, through the company's Dividend Reinvestment and Stock Purchase Plan. The transaction involved an optional cash contribution resulting in the acquisition of 6.18 shares at $24.27 each, totaling approximately $149. …
Thomas E. Chorman, serving as a director at Standex International Corp. (NYSE:SXI), executed a sale of company stock on July 1, 2026, totaling $17,775. The transaction, conducted at $355.51 per share, involved the disposal of 50 shares and was processed under a pre-arranged 10b5-1 trading plan established on November 6, 2025. Following this activit…
Wilson Terrance Lane, Senior Vice President and General Counsel at Williams Companies, Inc. (NYSE: WMB), recently executed a sale of 2,000 shares of the company's common stock on July 1, 2026, according to a filing with the Securities and Exchange Commission. The transaction, valued at $148,320, was conducted under a 10b5-1 sales plan established o…
Finward Bancorp director Robert E. Johnson III has increased his direct ownership in the regional financial institution through two distinct acquisition channels in mid-2026. The transactions, disclosed via Securities and Exchange Commission filings, highlight ongoing insider accumulation patterns while the company sustains its long-standing divide…
Ingrid A. Estrada, Senior Vice President at Keysight Technologies, Inc., executed a sale of 2,000 shares of the company's common stock on June 30, 2026. The transaction, valued at $681,740, was conducted at a price of $340.87 per share. This sale was carried out under a Rule 10b5-1 trading plan adopted by Ms. Estrada on March 30, 2026. Following th…
Pham Quang X, Chairman and CEO of Cadrenal Therapeutics, Inc. (NASDAQ:CVKD), executed a sale of 7,400 shares of common stock on June 29, 2026, resulting in gross proceeds of $22,422. The transaction was facilitated through a Rule 10b5-1 trading arrangement established on September 25, 2025. Following the divestment, Mr. Pham retains direct ownershi…
Sumedh S. Thakar, Chief Executive Officer and President of Qualys, Inc., liquidated a significant portion of his holdings on June 30, 2026, executing three separate sales that totaled approximately $4.05 million. The transactions, conducted under a Rule 10b5-1 trading plan established in February 2026, occurred as the cybersecurity firm's stock exp…
Fairmount Healthcare Fund II L.P., a key institutional investor in Oruka Therapeutics, Inc. (NASDAQ:ORKA), executed a substantial divestment of its common stock holdings on July 1, 2026. The transaction involved the sale of 3,553,410 shares, valued at approximately $300 million, shortly after converting Series B Preferred Stock into common equity. …
Airbnb director Kenneth I. Chenault executed a $1.25 million sale of 8,346 Class A Common Stock shares on June 29, 2026, following the exercise of fully vested stock options. The transaction, governed by a Rule 10b5-1 trading plan established in August 2025, occurred as the stock approached its 52-week high. Concurrently, the company navigates a co…
Joanne Imperial, a director at CapsoVision, Inc. (CV), executed a sale of 1,200 shares on June 8, 2026, generating $8,586. The transaction was reported via a late-amended Form 4/A, citing administrative delays in identifying the reportable event. Imperial retains 1,687 shares post-sale. The stock currently trades at $7.37, reflecting a 31% year-to-…
Kamal Ghaffarian, a director and significant shareholder of Intuitive Machines, Inc., executed a series of sales totaling approximately $2.9 million in Class A Common Stock on June 29, 2026. The transactions, facilitated through Ghaffarian Enterprises, LLC, were conducted under a Rule 10b5-1 trading plan established in late 2025. This activity occu…
Delek US Holdings, Inc. (NYSE:DK) director William J. Finnerty has executed a sale of 5,000 common shares on June 29, 2026, valued at $257,500. The transaction was conducted under a pre-arranged 10b5-1 trading plan, meaning it was scheduled in advance rather than being a reactive decision based on current market conditions. This sale brings Finnert…
Marc Crossman, serving as both Chief Financial Officer and Chief Operating Officer at Playboy, Inc. (NASDAQ: PLBY), executed multiple share sales between late June and early July 2026. The transactions, totaling $269,968, were strictly for tax withholding purposes related to restricted stock unit settlements. This activity occurs as the company's s…
CrowdStrike Holdings, Inc. (NASDAQ:CRWD) President and CEO George Kurtz completed a transaction on June 30, 2026, selling approximately $1.8 million worth of the company's Class A common stock. The sales, executed via a Rule 10b5-1 plan established on January 6, 2026, involved 2,322 shares traded at prices between $746.78 and $764.98. This activity…
Paul B. Prager, Chief Executive Officer of TeraWulf Inc. (NASDAQ: WULF), sold 137,500 shares of the company's common stock for a total of $3,656,950 on June 29, 2026. The transaction, executed indirectly through Beowulf E&D Holdings Inc., a vehicle where Mr. Prager serves as the sole manager, involved shares priced between $26.5800 and $27.5799, wi…
CrowdStrike Holdings Inc. CEO George Kurtz executed a series of share sales in late June 2026 under a pre-established 10b5-1 trading plan. Concurrently, the cybersecurity firm continues to broaden its security infrastructure through strategic partnerships with major cloud providers and AI platform developers.
Thrivent Financial for Lutherans, a major shareholder in Gloo Holdings, Inc. (NASDAQ:GLOO), has executed a series of sales totaling $94,079 in the company's Class A Common Stock. The divestment occurred across three consecutive days in late June and early July 2026, reducing the organization's direct ownership stake. This transaction takes place ag…
Jeffrey Grayson, Chief Financial Officer of DocuSign, Inc., executed a series of stock sales totaling $683,226 on July 1, 2026, under a Rule 10b5-1 trading plan. The transaction involved 15,000 shares sold across two blocks at prices ranging from approximately $44.95 to $46.04 per share. Following the sale, Grayson retains a direct holding of 141,4…
Paula Hansen, Chief Revenue Officer at DOCUSIGN, INC. (NASDAQ:DOCU), recently executed a transaction involving the sale of 6,000 shares of the company's common stock on July 1, 2026. The total value of this transaction was reported at $273,240. The shares were sold at prices ranging from $44.99 to $45.95 per share. Following this transaction, Ms. H…
Allan C. Thygesen, President and CEO of DocuSign, Inc. (NASDAQ:DOCU), completed the sale of 26,250 shares of the company's common stock on July 1, 2026, realizing a total transaction value of $1,208,131. The divestiture was executed through two distinct blocks under a Rule 10b5-1 trading plan, a structured mechanism designed to establish a predeter…
James P Shaughnessy, the Chief Legal Officer at DocuSign, Inc. (NASDAQ:DOCU), completed a stock sale totaling $546,478 on July 1, 2026. The disposal of 12,000 shares was carried out under a Rule 10b5-1 trading plan, a mechanism that allows insiders to schedule transactions in advance. This activity takes place while DOCU shares have fallen 29% over…
Joao Kleber Dos Santos Cardoso, Chief Financial Officer and Corporate Secretary at Aura Minerals Inc. (NASDAQ:AUGO), executed a significant divestment of company equity in late June 2026. The executive sold 59,999 common shares for approximately $3.7 million through a Rule 10b5-1 trading plan adopted earlier in the year. This transaction occurs aga…
Faeth Therapeutics CFO Brian Stephenson recently purchased 13,634 shares of company stock through multiple transactions between June 29 and July 1, 2026, totaling $326,127. The acquisition follows Faeth's integration into Sensei Biotherapeutics, which has triggered renewed analyst coverage and bullish price targets for the oncology-focused entity. …
REGENXBIO Inc. (NASDAQ:RGNX) Chief Medical Officer Steve Pakola recently completed a series of stock transactions totaling $688,755, executed under a Rule 10b5-1 trading plan. The sales coincided with the company's recent clinical progress in diabetic retinopathy and Duchenne muscular dystrophy, as well as regulatory alignment for its Mucopolysacch…
Frank J. Hanna III, a significant ten-percent owner of Atlanticus Holdings Corp (NASDAQ: ATLC), recently executed a series of stock sales totaling approximately $2.6 million. The transactions, which spanned three trading days from late June to early July 2026, occurred as the company's shares traded near their 52-week peak. This insider activity co…
